Search

In this article, the authors discuss the implications of the World Health Organization (WHO) recommendation of rapid diagnostic tests (RDTs) for malaria in Africa. They note that malaria treatment policies shifted to the expensive artemisinin-based combination therapy (ACT) and the guidelines prevent its overprescription. They cite a clinical trial, which found that the use of RDT had significant impact on clinical decisions. They also mention the adherence, safety and cost issues of RDT use.

Describes cases of blackwater fever (BWF) triggered by halofantrine, mefloquine and quinine among Italians living in Africa. Brief history for each of the cases; Importance of artemisinin derivatives in treating BWF.